2024 Q1 Form 10-K Financial Statement

#000126246324000015 Filed on January 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $0.00 $13.00K
YoY Change -100.0% -62.26%
Cost Of Revenue $5.885K
YoY Change -78.75%
Gross Profit $0.00 $7.115K
YoY Change -100.0% 5.28%
Gross Profit Margin 54.73%
Selling, General & Admin $1.384M
YoY Change 30.14%
% of Gross Profit 19450.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $32.25K $36.94K
YoY Change 3971.46%
% of Gross Profit 519.18%
Operating Expenses $523.1K $1.451M
YoY Change 140.64% 34.54%
Operating Profit -$522.7K -$1.441M
YoY Change 155.76% 34.54%
Interest Expense $6.932K $26.55K
YoY Change 14.54% 80.27%
% of Operating Profit
Other Income/Expense, Net $367.00 $2.104K
YoY Change 18250.0% 2743.24%
Pretax Income -$1.441M
YoY Change 34.54%
Income Tax
% Of Pretax Income
Net Earnings -$522.7K -$1.441M
YoY Change 155.76% 34.54%
Net Earnings / Revenue -11087.19%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 419.4M shares 352.4M shares
Diluted Shares Outstanding 419.4M shares 352.4M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $235.2K
YoY Change 360.11%
Cash & Equivalents $68.87K $235.2K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $125.3K $291.6K $291.6K
YoY Change 171.21% 171.21%
LONG-TERM ASSETS
Property, Plant & Equipment $866.1K $767.9K $767.9K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $136.7K $103.8K $203.8K
YoY Change 2897.35%
Total Long-Term Assets $1.081M $1.051M $1.051M
YoY Change 15357.1% 15357.06%
TOTAL ASSETS
Total Short-Term Assets $125.3K $291.6K $291.6K
Total Long-Term Assets $1.081M $1.051M $1.051M
Total Assets $1.206M $1.343M $1.343M
YoY Change 1074.65% 1074.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.144K $925.00 $930.00
YoY Change
Accrued Expenses $48.20K $41.27K $58.91K
YoY Change 180.27% 299.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $785.0K
YoY Change 26.61%
Total Short-Term Liabilities $1.106M $844.8K $844.8K
YoY Change 33.1% 33.1%
LONG-TERM LIABILITIES
Long-Term Debt $590.0K
YoY Change 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $590.0K $590.0K
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.106M $844.8K $844.8K
Total Long-Term Liabilities $590.0K $590.0K
Total Liabilities $1.696M $1.435M $1.435M
YoY Change 17.16% 17.16%
SHAREHOLDERS EQUITY
Retained Earnings -$42.13M -$41.61M
YoY Change 3.59%
Common Stock $41.59M $41.50M
YoY Change 6.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$489.4K -$92.20K -$92.20K
YoY Change
Total Liabilities & Shareholders Equity $1.206M $1.343M $1.343M
YoY Change 1074.65% 1074.65%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$522.7K -$1.441M
YoY Change 155.76% 34.54%
Depreciation, Depletion And Amortization $32.25K $36.94K
YoY Change 3971.46%
Cash From Operating Activities -$394.1K -$1.427M
YoY Change 108.94% 27.24%
INVESTING ACTIVITIES
Capital Expenditures $130.4K $804.9K
YoY Change 539.8%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$163.3K -$908.7K
YoY Change 701.26% 9086890.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.335M
YoY Change 23350230.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $391.1K $2.520M
YoY Change 38.68% 114.87%
NET CHANGE
Cash From Operating Activities -$394.1K -$1.427M
Cash From Investing Activities -$163.3K -$908.7K
Cash From Financing Activities $391.1K $2.520M
Net Change In Cash -$166.3K $184.1K
YoY Change -327.77% 260.11%
FREE CASH FLOW
Cash From Operating Activities -$394.1K -$1.427M
Capital Expenditures $130.4K $804.9K
Free Cash Flow -$524.5K -$2.232M
YoY Change 150.95% 99.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001342916
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022 hnoi Series Preferred Stock Returned To Treasury
SeriesPreferredStockReturnedToTreasury
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-56568
CY2023 dei Entity Registrant Name
EntityRegistrantName
HNO INTERNATIONAL, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2781289
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
4115 Eastman Drive
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite B
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Murrieta
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92562
CY2023 dei City Area Code
CityAreaCode
951
CY2023 dei Local Phone Number
LocalPhoneNumber
305-8872
CY2023 dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.001
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
16338419 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
419433085 shares
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
235159 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51109 usd
CY2023Q4 hnoi Due From Related Party
DueFromRelatedParty
56392 usd
CY2022Q4 hnoi Due From Related Party
DueFromRelatedParty
56392 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
291551 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
107501 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
767938 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
79324 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103821 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
100000 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
6800 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1051083 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
6800 usd
CY2023Q4 us-gaap Assets
Assets
1342634 usd
CY2022Q4 us-gaap Assets
Assets
114301 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
925 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41270 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14725 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17640 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 usd
CY2023Q4 hnoi Notes Payable Related Party Current
NotesPayableRelatedPartyCurrent
785000 usd
CY2022Q4 hnoi Notes Payable Related Party Current
NotesPayableRelatedPartyCurrent
620000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
844835 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
634725 usd
CY2023Q4 hnoi Long Term Notes Payable Related Party
LongTermNotesPayableRelatedParty
590000 usd
CY2022Q4 hnoi Long Term Notes Payable Related Party
LongTermNotesPayableRelatedParty
590000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1434835 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1224725 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
985000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
985000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
419341584 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
419341584 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105265299 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105265299 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
419341 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
105265 usd
CY2023Q4 hnoi Common Stock Payable
CommonStockPayable
32251 usd
CY2022Q4 hnoi Common Stock Payable
CommonStockPayable
0 usd
CY2023Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
23750 usd
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
10000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
41079902 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38957921 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41609945 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40168610 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-92201 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1110424 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1342634 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114301 usd
CY2023 us-gaap Revenues
Revenues
13000 usd
CY2022 us-gaap Revenues
Revenues
34450 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5885 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27692 usd
CY2023 us-gaap Gross Profit
GrossProfit
7115 usd
CY2022 us-gaap Gross Profit
GrossProfit
6758 usd
CY2023 hnoi Security Service
SecurityService
596 usd
CY2022 hnoi Security Service
SecurityService
0 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
22025 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3000 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4250 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
754159 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
472002 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40116 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19976 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20510 usd
CY2023 us-gaap Insurance Tax
InsuranceTax
5081 usd
CY2022 us-gaap Insurance Tax
InsuranceTax
0 usd
CY2023 us-gaap Interest Expense
InterestExpense
26545 usd
CY2022 us-gaap Interest Expense
InterestExpense
14725 usd
CY2023 hnoi Legal And Accounting Fees
LegalAndAccountingFees
126205 usd
CY2022 hnoi Legal And Accounting Fees
LegalAndAccountingFees
64237 usd
CY2023 hnoi Meals Expenses
MealsExpenses
1820 usd
CY2022 hnoi Meals Expenses
MealsExpenses
3795 usd
CY2023 hnoi Office Expenses
OfficeExpenses
4621 usd
CY2022 hnoi Office Expenses
OfficeExpenses
3453 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
145225 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
257337 usd
CY2023 us-gaap Salaries And Wages
SalariesAndWages
191636 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
145738 usd
CY2023 hnoi Payroll Service Fees
PayrollServiceFees
823 usd
CY2022 hnoi Payroll Service Fees
PayrollServiceFees
1064 usd
CY2023 hnoi Rental Expense
RentalExpense
60610 usd
CY2022 hnoi Rental Expense
RentalExpense
34400 usd
CY2023 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
43049 usd
CY2022 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
52921 usd
CY2023 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
5000 usd
CY2022 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
3269 usd
CY2023 hnoi Vehicle Expenses
VehicleExpenses
67 usd
CY2022 hnoi Vehicle Expenses
VehicleExpenses
440 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1450554 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1078141 usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
2104 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
74 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2104 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
74 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1441335 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1071309 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1441335 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1071309 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
352447298 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
352447298 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100230066 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100230066 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-39115 usd
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
10 usd
CY2022 hnoi Shares Cancelled For Cancellation Of Acquisition
SharesCancelledForCancellationOfAcquisition
-10 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1071309 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1110424 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1110424 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
290000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2025 usd
CY2023 hnoi Common Stock Issued For Settlement Of Debt
CommonStockIssuedForSettlementOfDebt
20000 usd
CY2023 hnoi Series Preferred Issued Pursuant To Patent Agreement
SeriesPreferredIssuedPursuantToPatentAgreement
82500 usd
CY2023 hnoi Regulation Common Stock Issuances
RegulationCommonStockIssuances
2045033 usd
CY2023 hnoi Common Stock Issued For Financing Commitment
CommonStockIssuedForFinancingCommitment
20000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1441335 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-92201 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-1441335 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1071309 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40116 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22025 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
925 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1932 usd
CY2023 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-0 usd
CY2022 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
56392 usd
CY2023 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-93200 usd
CY2022 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-6800 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
26545 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
14725 usd
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
17640 usd
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
0 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1427284 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1121708 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
250000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
620000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2335033 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10 usd
CY2023 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
0 usd
CY2022 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
590000 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
65000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
37183 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2520033 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1172827 usd
CY2023 us-gaap Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
-0 usd
CY2022 us-gaap Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
10 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
804878 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2023 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
103821 usd
CY2022 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
-0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-908699 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
184050 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
51109 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51109 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
235159 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51109 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 hnoi Series Preferred Stock Issued Pursuant To Patent Agreement
SeriesPreferredStockIssuedPursuantToPatentAgreement
82500 usd
CY2022 hnoi Series Preferred Stock Issued Pursuant To Patent Agreement
SeriesPreferredStockIssuedPursuantToPatentAgreement
0 usd
CY2023 hnoi Common Stock Issued For Conversion Of Debt
CommonStockIssuedForConversionOfDebt
20000 usd
CY2022 hnoi Common Stock Issued For Conversion Of Debt
CommonStockIssuedForConversionOfDebt
0 usd
CY2023 us-gaap Stock Issued1
StockIssued1
0 usd
CY2022 us-gaap Stock Issued1
StockIssued1
10 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_z5tliv0qUQC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_862_zqFZT2yfUq8d">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the condensed financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amount of revenues and expenses during the reporting period. The management makes its best estimate of the outcome for these items based on information available when the condensed financial statements are prepared.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
20000 usd
CY2021Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.01 pure
CY2022Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
20000 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2023Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
1375000 usd
CY2022Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
1210000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41609945 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
804878 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
0 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36940 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
-0 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
767938 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023 us-gaap Depreciation
Depreciation
36940 usd
CY2022 us-gaap Depreciation
Depreciation
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2023Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
82500 usd
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3176 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
79324 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3176 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
985000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
985000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
510000000 shares
CY2023Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
1000000000 shares
CY2023Q3 hnoi Stock Issued During Period Regulation A Stock Issuances Shares
StockIssuedDuringPeriodRegulationAStockIssuancesShares
1968032 shares
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2023Q3 hnoi Stock Issued During Period Regulation A Stock Issuance
StockIssuedDuringPeriodRegulationAStockIssuance
1968032 usd
CY2023Q4 hnoi Stock Issued During Period Regulation A Stock Issuances Shares
StockIssuedDuringPeriodRegulationAStockIssuancesShares
58500 shares
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2023Q4 hnoi Stock Issued During Period Regulation A Stock Issuance
StockIssuedDuringPeriodRegulationAStockIssuance
58500 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
419341584 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
419341584 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105265299 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105265299 shares
CY2023Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
6000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41270 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14725 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103821 usd

Files In Submission

Name View Source Status
0001262463-24-000015-index-headers.html Edgar Link pending
0001262463-24-000015-index.html Edgar Link pending
0001262463-24-000015.txt Edgar Link pending
0001262463-24-000015-xbrl.zip Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hnoi-20231031.xsd Edgar Link pending
hnoi-20231031_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
hnoi-20231031_lab.xml Edgar Link unprocessable
hnoi-20231031_def.xml Edgar Link unprocessable
hnoi10k103123.htm Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hnoi-20231031_pre.xml Edgar Link unprocessable
hnoi10k103123_htm.xml Edgar Link completed